Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

NCT01025089

Conditions
Clinical Masaoka Stage II to IVA, Hemic and Lymphatic Diseases, Lymphatic Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
Locations
  • Massachusetts General Hospital . Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.

NCT06441214

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia Alessandria, Italy
  • A.O.U. Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
  • Ospedale C. e G. Mazzoni - U.O.C. di Ematologia Ascoli Piceno, Italy
  • AOU Policlinico Consorziale - U.O. Ematologia con Trapianto Bari, Italy
View all 28 locations
View Trial Details
Active, Not Recruiting

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

NCT04882475

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy
  • AOU Senese - U.O.C. Ematologia Siena, SI, Italy
  • Centro Riferimento Oncologico - S.O.C. Oncologia Medica A Aviano, Italy
  • ASST Spedali Civili di Brescia - Ematologia Brescia, Italy
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

NCT05228158

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Eisai Trial Site 131 Komaki-shi, Aichi-ken, Japan
  • Eisai Trial Site 199 Konan-shi, Aichi-ken, Japan
  • Eisai Trial Site 21 Nagakute-shi, Aichi-ken, Japan
  • Eisai Trial Site 106 Nagoya, Aichi-ken, Japan
View all 135 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

NCT05952037

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 72 locations
View Trial Details

Related conditions